These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 9387872)
1. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity. Thiffault C; Quirion R; Poirier J Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872 [TBL] [Abstract][Full Text] [Related]
2. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse. Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165 [TBL] [Abstract][Full Text] [Related]
3. The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase. Clow A; Freestone C; Lewis E; Dexter D; Sandler M; Glover V Neurosci Lett; 1993 Dec; 164(1-2):41-3. PubMed ID: 8152612 [TBL] [Abstract][Full Text] [Related]
4. Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain. Thiffault C; Quirion R; Poirier J Synapse; 1998 Mar; 28(3):208-11. PubMed ID: 9488505 [TBL] [Abstract][Full Text] [Related]
5. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. Tatton WG; Wadia JS; Ju WY; Chalmers-Redman RM; Tatton NA J Neural Transm Suppl; 1996; 48():45-59. PubMed ID: 8988461 [TBL] [Abstract][Full Text] [Related]
6. Improvement of mouse brain mitochondrial function after deprenyl treatment. Czerniczyniec A; Bustamante J; Lores-Arnaiz S Neuroscience; 2007 Jan; 144(2):685-93. PubMed ID: 17084986 [TBL] [Abstract][Full Text] [Related]
7. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease. Youdim MB; Tipton KF Parkinsonism Relat Disord; 2002 Mar; 8(4):247-53. PubMed ID: 12039419 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates. Thomas CE; Huber EW; Ohlweiler DF Free Radic Biol Med; 1997; 22(4):733-7. PubMed ID: 9013137 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. Paterson IA; Juorio AV; Berry MD; Zhu MY J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846 [TBL] [Abstract][Full Text] [Related]
10. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor. Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930 [TBL] [Abstract][Full Text] [Related]
11. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B]. Knoll J Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I; Youdim MB; Finberg JP J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937 [TBL] [Abstract][Full Text] [Related]
13. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658 [TBL] [Abstract][Full Text] [Related]
14. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant. Seif-El-Nasr M; Atia AS; Abdelsalam RM Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum. Vizuete ML; Steffen V; Ayala A; Cano J; Machado A Neurosci Lett; 1993 Apr; 152(1-2):113-6. PubMed ID: 8515861 [TBL] [Abstract][Full Text] [Related]
16. L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells. Li XM; Juorio AV; Qi J; Boulton AA J Neurosci Res; 1998 Jul; 53(2):235-8. PubMed ID: 9671980 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145. Azam M; Jain S; Baquer NZ Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104 [TBL] [Abstract][Full Text] [Related]
18. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity]. Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204 [TBL] [Abstract][Full Text] [Related]
19. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B. Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076 [TBL] [Abstract][Full Text] [Related]
20. High-throughput screening and radioligand binding studies reveal monoamine oxidase-B as the primary binding target for d-deprenyl. Lesniak A; Aarnio M; Jonsson A; Norberg T; Nyberg F; Gordh T Life Sci; 2016 May; 152():231-7. PubMed ID: 27058977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]